Propylene Glycol Monolaurate
Dodecanoic acid, monoester with 1,2-propanediol. Lauric acid, monoester with propane-1,2-diol. » Propylene Glycol Monolaurate is a mixture of the propylene glycol mono- and di-esters of lauric acid. The requirements for monoester and diester content differ for the two types of Propylene Glycol Monolaurate, as set forth in the accompanying table.
Packaging and storage—
Preserve in well-closed containers, and protect from moisture. No storage requirements specified.
Labeling—
Label it to indicate the type (Type I or Type II).
Change to read:
USP Reference standards ![]() ![]() USP Propylene Glycol RS ![]() ![]() ![]() ![]() USP Propylene Glycol Monolaurate Type II RS. ![]()
Change to read:
Identification—
A: Thin-Layer Chromatographic Identification Test
![]() ![]() ![]() ![]()
Test solution:
50 mg per mL, in methylene chloride.
Developing solvent solution:
a mixture of hexane and ether (30:70)
Spray reagent—
Prepare a 0.1 mg per mL solution of rhodamine 6G in alcohol.
Procedure—
Develop the chromatogram over a path of 15 cm, and dry the plate in a current of air. Spray the plate with Spray reagent, and locate the spots on the plate by examination under UV light at a wavelength of 365 nm: the RF values of the principal spots obtained from the Test solution correspond to those obtained from the
![]() ![]()
B:
It complies with the requirements of the test for Fatty acid composition.
Acid value
![]() ![]()
Iodine value
![]() ![]()
Saponification value
![]() ![]()
Fatty acid composition
![]() ![]()
Water, Method Ia
![]() ![]()
Total ash
![]() ![]()
Limit of propylene glycol—
Mobile phase—
Proceed as directed in the Assay.
Propylene glycol standard stock solution—
Prepare a solution containing a known concentration of about 4 mg per mL of USP Propylene Glycol RS in tetrahydrofuran.
Propylene glycol standard solutions—
Into four 15-mL flasks, introduce respectively, 0.25 mL, 0.5 mL, 1.0 mL, and 2.5 mL of Propylene glycol standard stock solution, and dilute with tetrahydrofuran to 5.0 mL. In a fifth 15-mL flask, introduce 5.0 mL of Propylene glycol standard stock solution.
Test solution—
Use the Assay preparation.
Chromatographic system—
Proceed as directed in the Assay.
Procedure—
Separately inject equal volumes (about 40 µL) of the Propylene glycol standard solutions and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Prepare a standard curve of peak area versus concentration, in mg per mL, of propylene glycol in the Propylene glycol standard solutions. Obtain the concentration, C, in mg per mL, of propylene glycol in the Test solution from the standard curve. Calculate the percentage of free propylene glycol in the portion of Propylene Glycol Monolaurate taken by the formula:
100CV/W
in which V is the final volume of the Test solution; and W is the weight, in mg, of Propylene Glycol Monolaurate used to prepare the Test solution: not more than 5.0% is found for propylene glycol monolaurate (Type I); and not more than 1.0% is found for propylene glycol monolaurate (Type II).
Assay—
Mobile phase:
tetrahydrofuran.
Assay preparation—
Accurately weigh about 200 mg of Propylene Glycol Monolaurate into a 15-mL flask, add 5 mL of tetrahydrofuran, and shake to dissolve.
Chromatographic system (see Chromatography
![]() ![]() ![]()
Procedure—
Inject a volume (about 40 µL) of the Assay preparation into the chromatograph, record the chromatogram, and measure the responses for the major peaks. Calculate the percentage of monoesters or diesters in the portion of Propylene Glycol Monolaurate taken by the formula:
(100
in which D is the sum of the percentage content of propylene glycol and percentage content of free fatty acids; rU is the peak response for monoesters or diesters; and rs is the sum of the responses of the monoesters and diesters peaks. Calculate the percentage content of free fatty acids using the formula:
![]() 200(A/561.1)
in which A is the acid value.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
USP32–NF27 Page 1328
Pharmacopeial Forum: Volume No. 34(1) Page 140
|